Vaccines delivered under COVAX sharing scheme for poorer countries --data

Factbox: Vaccines delivered under COVAX sharing scheme for poorer countries The COVAX facility, backed by the World Health Organization (WHO) and the Global Alliance for Vaccines and Immunization (GAVI), has delivered 1.34 billion COVID-19 vaccine doses to 144 countries, GAVI data shows. Reuters Reuters

March 4 (Reuters) - The COVAX facility, backed by the World Health Organization (WHO) and the Global Alliance for Vaccines and Immunization (GAVI), has delivered 1.34 billion COVID-19 vaccine doses to 144 countries, GAVI data shows.

In December COVAX set a target of achieving 70% COVID-19 immunization coverage by mid-2022.

The following tables list countries that have received vaccines under the scheme, sorted alphabetically:

AFRICA & MIDDLE EAST

COUNTRY	LATEST DELIVERY	DELIVERY DATE	VACCINE TYPE	POPULATION	TOTAL DELIVERED
Algeria	3.6 million	December 24	J&J	44 million	6.0 million
Angola	801,000	December 25	Pfizer/BioNTech	33 million	14.8 million
Benin	336,000	November 4	J&J	12 million	1.1 million
Botswana	300,000	October 1	AstraZeneca/Oxford	2.5 million	560,460
Burkina Faso	504,000	December 22	J&J	21 million	1.1 million
Cameroon	336,000	November 5	J&J	27 million	1.0 million
Cape Verde	200,000	December 7	Pfizer/BioNTech	556,000	324,000
Central African Republic	168,300	November 19	J&J	4.8 million	806,700
Chad	117,000	October 5	Pfizer/BioNTech	16 million	217,620
Comoros Islands	12,000	April 12	AstraZeneca/Oxford	870,000	12,000
Congo	168,000	November 15	J&J	5.5 million	470,400
Democratic Republic of Congo	349,830	October 21	Pfizer/BioNTech	90 million	2.6 million
Djibouti	151,200	July 17	J&J	988,000	175,200
Egypt	2.2 million	February 20	Pfizer/BioNTech	102 million	29.0 million
Eswatini	100,620	October 6	Pfizer/BioNTech	1.1 million	429,420
Ethiopia	13.1 million	February 2	J&J	115 million	27.5 million
Gabon	101,790	November 1	Pfizer/BioNTech	2.2 million	370,410
Gambia	100,620	March 3	Pfizer/BioNTech	2.4 million	477,420
Ghana	1.7 million	December 24	Pfizer/BioNTech	31 million	16.3 million
Guinea	168,000	November 14	J&J	13 million	1.7 million
Guinea-Bissau	28,800	August 18	AstraZeneca/Oxford	2.0 million	360,000
Iran	700,000	January 14	AstraZeneca/Oxford	84 million	5.7 million
Iraq	500,000	August 14	Pfizer/BioNTech	40 million	836,000
Ivory Coast	816,660	January 3	Pfizer/BioNTech	26 million	8.6 million
Jordan	146,400	June 3	AstraZeneca/Oxford	10 million	436,800
Kenya	1.9 million	February 28	Pfizer/BioNTech	54 million	18.6 million
Lebanon	613,340	December 22	N/A	6.8 million	982,940
Lesotho	169,070	November 19	J&J	2.1 million	644,090
Liberia	168,000	November 27	J&J	5.1 million	830,400
Libya	1.2 million	December 20	Pfizer/BioNTech	6.9 million	1.9 million
Madagascar	240,000	February 17	J&J	28 million	1.9 million
Malawi	277,080	February 26	AstraZeneca/Oxford	19 million	2.0 million
Mali	50,400	January 7	AstraZeneca/Oxford	20 million	1.7 million
Mauritania	201,600	February 7	AstraZeneca/Oxford	4.6 million	2.2 million
Mauritius	203,580	January 12	Pfizer/BioNTech	1.3 million	387,270
Morocco	1.5 million	January 29	Pfizer/BioNTech	37 million	2.7 million
Mozambique	1.2 million	February 11	AstraZeneca/Oxford	31 million	8.4 million
Namibia	19,890	February 18	Pfizer/BioNTech	2.5 million	512,690
Niger	398,000	February 4	Pfizer/BioNTech	24 million	1.6 million
Nigeria	2.0 million	February 7	J&J	206 million	17.2 million
Palestinian Territories	203,580	January 31	Pfizer/BioNTech	4.7 million	1.3 million
Rwanda	1.1 million	January 15	N/A	13 million	3.9 million
Sao Tome and Principe	24,000	March 3	AstraZeneca/Oxford	219,000	24,000
Senegal	302,400	February 10	J&J	17 million	3.2 million
Seychelles	39,780	December 17	Pfizer/BioNTech	98,460	74,880
Sierra Leone	168,000	November 23	J&J	8.0 million	785,310
Somalia	250,380	March 3	Pfizer/BioNTech	16 million	1.4 million
South Africa	5.6 million	July 31	Pfizer/BioNTech	59 million	5.6 million
South Sudan	336,000	December 21	J&J	11 million	908,450
Sudan	604,800	February 16	J&J	44 million	3.9 million
Syria	4.0 million	January 26	J&J	17 million	5.7 million
Tanzania	1.6 million	January 19	Pfizer/BioNTech	60 million	4.7 million
Togo	633,600	November 25	J&J	8.3 million	3.0 million
Tunisia	310,050	January 28	Pfizer/BioNTech	12 million	4.4 million
Uganda	433,300	February 16	Moderna	46 million	11.7 million
Yemen	100,800	February 24	AstraZeneca/Oxford	30 million	2.2 million
Zambia	907,200	January 28	N/A	18 million	4.0 million
Zimbabwe	2.6 million	January 19	N/A	15 million	3.5 million

EUROPE

COUNTRY	LATEST DELIVERY	DELIVERY DATE	VACCINE TYPE	POPULATION	TOTAL DELIVERED
Albania	40,800	June 2	AstraZeneca/Oxford	2.8 million	120,000
Armenia	187,200	September 5	AstraZeneca/Oxford	3.0 million	261,200
Azerbaijan	84,000	April 4	AstraZeneca/Oxford	10 million	84,000
Bosnia	32,760	May 10	Pfizer/BioNTech	3.3 million	82,560
Georgia	43,200	March 13	AstraZeneca/Oxford	3.7 million	43,200
Kosovo	515,970	February 10	Pfizer/BioNTech	1.8 million	1.2 million
Moldova	100,620	January 27	Pfizer/BioNTech	2.6 million	744,620
Montenegro	24,000	March 28	AstraZeneca/Oxford	622,000	24,000
North Macedonia	250,380	February 7	Pfizer/BioNTech	2.1 million	312,780
Serbia	115,200	August 25	AstraZeneca/Oxford	6.9 million	292,800
Ukraine	1.0 million	January 19	Pfizer/BioNTech	44 million	8.8 million

ASIA & PACIFIC

COUNTRY	LATEST DELIVERY	DELIVERY DATE	VACCINE TYPE	POPULATION	TOTAL DELIVERED
Afghanistan	2.0 million	February 2	J&J	39 million	9.0 million
Bangladesh	342,400	February 2	Pfizer/BioNTech	165 million	34.8 million
Brunei	24,000	April 2	AstraZeneca/Oxford	437,000	24,000
Cambodia	300,000	December 19	AstraZeneca/Oxford	17 million	2.9 million
East Timor	100,620	February 12	Pfizer/BioNTech	1.3 million	494,040
Fiji	50,400	November 18	Moderna	896,000	302,480
Indonesia	2.6 million	January 28	AstraZeneca/Oxford	274 million	48.8 million
Kiribati	56,000	August 21	AstraZeneca/Oxford	119,000	104,000
Kyrgyzstan	149,760	February 1	Pfizer/BioNTech	6.6 million	800,300
Laos	1.7 million	January 26	Pfizer/BioNTech	7.3 million	7.6 million
Malaysia	559,200	September 17	AstraZeneca/Oxford	32 million	1.4 million
Maldives	210,600	January 28	Pfizer/BioNTech	541,000	664,540
Mongolia	899,730	October 6	Pfizer/BioNTech	3.3 million	1.3 million
Nauru	7,200	April 2	AstraZeneca/Oxford	10,830	7,200
Nepal	800,000	February 7	AstraZeneca/Oxford	29 million	14.2 million
Pakistan	1.5 million	December 28	Moderna	221 million	39.1 million
Papua New Guinea	302,400	August 6	J&J	8.9 million	580,400
Philippines	769,860	March 3	Pfizer/BioNTech	110 million	52.6 million
Samoa	112,000	August 23	AstraZeneca/Oxford	198,410	136,000
Solomon Islands	100,620	November 16	Pfizer/BioNTech	687,000	209,420
Sri Lanka	820,000	December 20	Pfizer/BioNTech	22 million	5.0 million
Tajikistan	501,200	February 21	AstraZeneca/Oxford	9.5 million	5.4 million
Tonga	7,000	February 15	N/A	106,000	67,800
Tuvalu	4,800	April 8	AstraZeneca/Oxford	11,800	4,800
Uzbekistan	2.8 million	February 17	Moderna	34 million	12.7 million
Vanuatu	24,000	May 19	AstraZeneca/Oxford	307,000	24,000
Vietnam	6.3 million	January 25	Pfizer/BioNTech	97 million	38.7 million

AMERICAS

COUNTRY	LATEST DELIVERY	DELIVERY DATE	VACCINE TYPE	POPULATION	TOTAL DELIVERED
Antigua and Barbuda	19,200	November 22	N/A	98,000	60,000
Argentina	960,400	October 12	AstraZeneca/Oxford	45 million	3.9 million
Bahamas	57,330	October 18	Pfizer/BioNTech	393,000	124,530
Barbados	14,040	December 16	Pfizer/BioNTech	287,000	114,840
Belize	58,500	October 26	Pfizer/BioNTech	398,000	159,300
Bermuda	9,600	April 6	AstraZeneca/Oxford	64,000	9,600
Bolivia	1.3 million	February 16	Pfizer/BioNTech	12 million	8.0 million
Brazil	2.0 million	September 20	Sinovac	213 million	11.9 million
Chile	331,000	May 20	AstraZeneca/Oxford	19 million	489,400
Colombia	117,000	March 1	Pfizer/BioNTech	51 million	16.6 million
Costa Rica	200,070	February 28	Pfizer/BioNTech	5.1 million	1.6 million
Dominica	30,240	February 4	Moderna	72,000	133,920
Dominican Republic	184,800	August 27	AstraZeneca/Oxford	11 million	463,200
Ecuador	1.5 million	February 15	Pfizer/BioNTech	18 million	3.8 million
El Salvador	188,370	August 27	Pfizer/BioNTech	6.5 million	3.6 million
Grenada	69,030	December 16	Pfizer/BioNTech	113,000	114,630
Guatemala	680,940	January 27	Pfizer/BioNTech	17 million	5.0 million
Guyana	28,800	January 14	J&J	787,000	291,540
Haiti	151,200	February 14	Moderna	11 million	1.1 million
Honduras	250,040	October 28	Moderna	9.9 million	4.8 million
Jamaica	100,000	February 21	AstraZeneca/Oxford	3.0 million	1.7 million
Mexico	4.0 million	March 4	AstraZeneca/Oxford	129 million	21.3 million
Nicaragua	993,600	January 24	J&J	6.6 million	4.7 million
Panama	74,400	September 15	AstraZeneca/Oxford	4.3 million	148,800
Paraguay	466,830	January 24	Pfizer/BioNTech	7.1 million	1.7 million
Peru	1.2 million	November 10	Sinopharm	33 million	3.6 million
Saint Kitts and Nevis	21,600	April 7	AstraZeneca/Oxford	53,000	21,600
Saint Lucia	7,200	December 28	J&J	184,000	197,430
Saint Vincent and the Grenadines	70,200	December 14	Pfizer/BioNTech	111,000	115,800
Suriname	64,800	December 14	AstraZeneca/Oxford	587,000	144,000
Trinidad and Tobago	84,000	November 27	Sinopharm	1.4 million	185,200
Uruguay	50,400	September 1	AstraZeneca/Oxford	3.5 million	148,800
Venezuela	3.1 million	January 17	Sinopharm	28 million	12.1 million